Cheminformatic Tools and Databases for Pharmacology

session 78503 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
ENCORAFENIB

ENCORAFENIB


ATC L01EC03

ANTINEOPLASTIC
BRAF V600E KINASE INHIBITOR (KD=0.35 NANOMOLAR)
TREATMENT OF MELANOMA WITH A BRAF V600E OR V600K MUTATION
ALSO BINDS JNK1, JNK2, JNK3, LIMK1, LIMK2, MEK4, AND STK36 KINASES

ORAL

Tmax 2 HOUR

F 86 PERCENT

VD 164 LITER

PPB 86 PERCENT

Cl 14 LITER / HOUR

HT 3.5 HOUR

SOLUBILITY INSOLUBLE IN WATER AT PH 3 AND HIGHER

BRAF

RAF proto-oncogene serine,threonine-protein kinase UNIPROT P04049 RAF1 -- Serine,threonine-protein kinase B-raf UNIPROT P15056 BRAF

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |